Isolation- drug resistance profile and molecular characterization of indigenous typical and atypical mycobacteria

Pakistan Journal of Pharmaceutical Sciences

Volumn 24, Issue 4, 2011, Pages 527-532

  Khanum, Tanveer ^a   Rasool, Sheikh Ajaz ^a   Ajaz, Munazza ^b   Khan, Asif Iqbal ^c  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b FEDERAL URDU UNIVERSITY OF ARTS   (Pakistan)

^c DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

Author keywords

Atypical mycobacteria; Conventional methods; Drug sensitivity profile; Multiplex PCR; Typical mycobacteria

Indexed keywords

AMIKACIN; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG ISOLATION; MYCOBACTERIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TERRAE; MYCOBACTERIUM THERMORESISTIBLE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM XENOPEI; NONHUMAN; PHENOTYPE;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; NONTUBERCULOUS MYCOBACTERIA; PAKISTAN; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S;

EID: 80053453928     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Acharya S, Ghimire P, Khadka DK and Nepali S (2008).Comparison of Proportion and Resistance Ratio Methods for Drug Susceptibility Testing of Mycobacterium tuberculosis Isolated from Patients Attending National Tuberculosis Centre, Nepal. SAARC J. Tuber. Lung Dis. HIV/AIDS, 5(1): 13-20.
2. Agarwal NJ (2001). Isolation rates of non-tuberculous mycobacteria from Amritsar Indian. J. Med. Microbiol., 19(4): 230-231.
3. Becerra MC, Freeman J, Bayona J, Shin SS, Furin JJ, Kim JY, Werner B, Timperi R, Sloutsky A, Wilson ME, Pagano M, Farmer PE (2000). Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int. J. Tuberc. Lung Dis., 4: 108-114. (Pubitemid 30123642)
4. Bollo E, Guarda F, Capucchio MT and Galiett F (1998). Direct Detection of Mycobacterium tuberculosis complex and M. avium complex in tissue specimens from cattle through identification of specific rRNA sequences. J. Vet. Med.,Series B. 45: 395-400. (Pubitemid 128531141)
5. Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL. (1996). An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS, 10: 299-309. (Pubitemid 26093490)
6. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baéz J, Kochi A, Dye C, Raviglione MC (2000). Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA, 283: 2537-2545. (Pubitemid 30324196)
7. Floyd K, Blanc K, Raviglione M and Jong-Wook L (2002). Resources required for global tuberculosis control. Science. 295 (5562): 2040-2041 (Pubitemid 34229457)
8. Falzon D, Glaziou P, Jaramillo E, Mirzayev F, Nathanson E, Sismanidis C, Gemert W, Weil D and Zignol M. (2010). Multidrug and extensively drug-resistant TB (MDR/XDR). 2010 global report on surveillance and response. World Health Organization., pp.1.
9. Gopinath K and Singh S (2009). Multiplex PCR assay for simultaneous detection and differentiation of Mycobacterium tuberculosis, Mycobacterium avium complexes and other Mycobacterial species directly from clinical specimens. J. Appl Microbiol., 107: 425-435.
10. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH (2010). HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J. Respir. Crit. Care Med., 181: 80-86.
11. Kent PT, Kubica GP (1985) Public health Mycobacteriology : a guide for the level III laboratory. US Department of health and human services, Publication no. (CDC) 86-8230 Center for Disease Control., Atlanta.
12. Kapur V, Li LL, Hamrick MR, Plikaytis BB, Shinnick TM, Telenti A, Jacobs WR, Banerjee A, Cole ST, Yuen KY, Clarridge JE, Kreiswirth BN and Musser JM (1995). Rapid species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch. Pathol. Lab. Med., 119: 131-138.
13. Kazda JF(1983). The principles of ecology of mycobacteria. In: Biology of Mycobacteria, Stanford JL, Ratledge C, (editors) Vol.2. Academic Press, London, 323-342.
14. Katoch VM (2004). Infections due to non-tuberculous mycobacteria (NTM) Indian J. Med. Res., 120: 290-304.
15. st edition Sharma SK (editor). Katoch)(editor), Jaypee Brothers Medical Publishers (P) Ltd., New Delhi, p.439-451.
16. MacArthur A, Gloyd S, Perdigao P, Noya A, Sacarlal J, Kreiss J. (2001). Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. Int. J. Tuberc. Lung Dis., 5: 894-902. (Pubitemid 32976632)
17. Mawak JD, Gomwalk NE, Bello CSS and Kandakai- Olukemi YT (2006). Human pulmonary infections with bovine and environment (Atypical) mycobacteria in Jos, Nigeria. Ghana Med. J., 40(4): 132-136.
18. Ngan N, Morris A and Chalain T (2005). Mycobacterium fortuitum infection caused by a cat bite. N Z. Med J., 118: 1211.
19. Niemann S, Richter E, Dalügge-Tamm H, Schlesinger H, Graupner D, Königstein B, Gurath G, Greinert U and Rüsch-Gerdes S (2000). Two cases of Mycobacterium microti derived tuberculosis in HIV-negative immunocompetent patients. Emerg. Infect. Dis., 6(5): 539-542.
20. O'Brien R (1994). Drug-resistant tuberculosis: etiology, management and prevention. Semin. Respir. Infect., 9(2): 104-112.
21. Porat MD and Austin MS (2008). Bilateral knee periprosthetic infection with Mycobacterium fortuitum. J. Arthroplasty, 23: 787-789.
22. Prendki V, Germaud P, Bemer P, Masseau A and Hamidou M (2008). Les infectious a mycobactéries non tuberculeuses. La Revue de Médicine Interne, 29: 370-379.
23. th edition, Murray JF (editor). ASM Press, Washington, D.C p.551.
24. Roth A, Reischl U, Streubel A, Naumann L, Kroppenstedt RM, Habicht M, Fischer M, Mauch H (2000). Novel diagnostic algorithm for identification of mycobacteria using genus specific amplification of 16S-23S rRNA gene spacer and restriction endonucleases. J. Clin. Microbiol., 38: 1094-1104. (Pubitemid 30140566)
25. Robert Horsburgh C Jr (2000). The global problem of multidrug-resistant tuberculosis. The Genie is out of the Bottle. JAMA., 283: 2575-2576.
26. Sachdev R, Gadre DV and Talwar V (2002). Characterization and susceptibility pattern of extrapulmonary isolates. Indian J. Med. Res., 115: 102-107.
27. Stratmann J, Strommenger B, Stevenson K and Gerlach GF (2002). Development of peptide mediated capture of PCR for detection of Mycobacterium avium subsp paratuberculosis in milk. J. Clin. Microbiol., 40: 4244-4250. (Pubitemid 35285820)
28. nd Ed.). 10.51-10.67.
29. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S and Hasan R (2008). Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. B.M.C. Infect. Dis., 8(1): 171.
30. Tsukamura M, Kita N, Shimoide H, Arakawa H and Kuze A (1988). Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am. Rev. Respir. Dis., 137: 1280-1284.
31. van Crevel R, De Lange WC, Vanderpuye NA, van Soolingen D, Hoogkamp-Korstanje JA, van Deuren KM, Kullberg BJ, van Herwaarden C and van der Meer JW (2001). The impact of nontuberculous mycobacteria on management of presumed pulmonary tuberculosis. Infection, 29(2): 59-63. (Pubitemid 32319639)
32. Wayne IG and Sramek HA (1992). Agents of newly recognised or infrequently encountered mycobacterial diseases. Clin. Microbiol. Rev., 5: 1-25.
33. Wallace RJ J, O'Brein R, Glassroth J, Raleigh J and Dutta A (1990). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. Rev. Respir. Dis., 142: 940-953.
34. Wallace RJ (1989). The clinical presentation, diagnosis and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. Clin. Chest Med., 10: 419-429.
35. Wolinsky E (1979). Non-tuberculous mycobaceria and associated diseases. Am. Rev. Resp. Dis., 119: 107-159.